Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence‐free survival in patients with non‐muscle‐invasive bladder cancer
Authors:
- 19 March 2021
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 28 (7) , 727-732
Abstract
Objective: To elucidate the therapeutic benefits of using a surgical checklist during transurethral resection for non‐muscle‐invasive bladder cancer.Methods: A nine‐item surgical checklist was established in January 2016 to assess disease risk and resection adequacy, and it was prospectively implemented into clinical practice. Patients diagnosed with non‐muscle‐invasive bladder cancer who underwent complete resection from January 2009 to August 2019 were included in this study. The presence of detrusor muscle in the transurethral resection specimen and the intravesical recurrence‐free survival were compared between patients who underwent transurethral resection before and after surgical checklist implementation.Results: A total of 125 patients who underwent transurethral resection after surgical checklist implementation were reviewed and compared with 125 patients who underwent transurethral resection before surgical checklist implementation. The use of the surgical checklist led to an increase in the proportion of transurethral resection specimens containing detrusor muscle (92% vs 69.6%, P < 0.01) and a decrease in the recurrence rate (19.2% vs 49.6%, P < 0.01). Multivariate analysis showed that transurethral resection without a surgical checklist was an independent predictive factor influencing the absence of detrusor muscle in the transurethral resection specimen (odds ratio 4.78, P < 0.01) and intravesical recurrence (hazard ratio 1.92, 95% confidence interval 1.14–3.23; P = 0.01). Kaplan–Meier plots showed that the recurrence‐free survival rate was significantly lower when the surgical checklist was not used (log‐rank test result P < 0.01).Conclusions: This study shows the therapeutic benefits of surgical checklist in improving the quality of resection during transurethral resection and reducing the recurrence rate in patients with non‐muscle‐invasive bladder cancer.Keywords
This publication has 17 references indexed in Scilit:
- Comparison of Detrusor Muscle Sampling Rate in Monopolar and Bipolar Transurethral Resection of Bladder Tumor: A Randomized TrialAnnals of Surgical Oncology, 2016
- A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder TumorJournal of Urology, 2016
- Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of MaintenanceEuropean Urology, 2013
- Narrow band imaging diagnosis of bladder cancer: systematic review and meta‐analysisBJU International, 2012
- The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder Tumor ChecklistEuropean Urology, 2012
- Impact of Routine Second Transurethral Resection on the Long-Term Outcome of Patients with Newly Diagnosed pT1 Urothelial Carcinoma with Respect to Recurrence, Progression Rate, and Disease-Specific Survival: A Prospective Randomised Clinical TrialEuropean Urology, 2010
- Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator ExperienceEuropean Urology, 2010
- Photodynamic Diagnosis in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective StudiesEuropean Urology, 2010
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC StudiesEuropean Urology, 2002